1

Johnson & Johnson Innovation Genesis December 9, 2014

CONFIDENTIAL: For internal use only

2

Our vision is to positively impact human health through innovation. We do this by helping entrepreneurs realize their dreams of creating healthcare solutions that improve peoples’ lives around the world. We work side-by-side with innovators throughout their journey, providing a robust exchange of ideas and resources to support their success.

Innovation is everywhere, but mostly outside of our own organization

California London

Boston Shanghai

San Diego Israel

Innovation Center Satellite

Russia

Singapore

Australia

Japan

4

4

Transformational

Idea

Right Solution – JLABS – Advice + Mentorship – Incubation & Seed

Financing – Venture Financing – Investment Partners – Strategic LP

Relationships – R&D Collaborations – Soft and Call Options – Licensing – Acquisition

With our combined resources, how can we work together to bring the idea to the next stage of its development?

Custom Collaboration Solutions to Meet the Unique Needs of Each Innovation

Assess Options

5

An Experienced and Expert Team

5

An integrated team of industry experts...

...supporting the development of innovative pharmaceuticals, medical

devices, diagnostics and consumer products

R&D Product Development Commercialisation

One Chapel Place London W1G 0BG

http://www.jnjinnovation.com/

Patrick Verheyen – Head, London Innovation Centre

London Team Satellites: Israel & Russia

6

Jeanne Bolger, JJDC/Investor Zeev Zehavi, JJDC/Investor Kurt Hertogs, Platform Technologies/Incubators Roger Bone, Transactions Anthony Gemmell, Transactions Yelda Kaya, Transactions Johan Verbeeck, Alliance Management Kristof Van Emelen, Discovery Sciences Iqbal Hussain, Legal Affairs

Ann Connolly, New Ventures Joni Catalano-Sherman, New Ventures Daniel Janse, New Ventures

Chris Janssen, External Innovation, Russia

Rit Boeckx, Office Manager

Lily Cortese, Project Management

Laurent Morlet, Information Technology

Ellen Rose, Communication & External Affairs

Mohit Vatsa, Finance

THERAPEUTIC AREA LEADS

Immunology Oncology CV Metabolic

Neuroscience Microbiome /Vaccines

Infectious Disease

Consumer

Ian Anderson Louise Jopling

Omid Vafa

Karin Conde-Knape

Declan Jones

Anthony Williamson

Kenny Simmen

Elena Fernandez-

Kleinlein

7 CONFIDENTIAL: For internal use only

Cardiovascular & Metabolism Immunology Infectious Diseases & Vaccines Neuroscience Oncology

General Surgery Biosurgery Orthopedics Vision Care Infection Care Diabetes Energy Cardiovascular Ear, Nose, Throat Neuroscience Aesthetics

Well-being & beauty Baby care Body care Facial skin care Sun care Feminine personal care

Health & Healing Allergy care Compromised skin Cough & cold care Digestive health Oral care Pain care

A Closer Look at Our Pharmaceutical Therapy Areas

8

Cardiovascular and Metabolism

– Type 2 Diabetes – Heart Failure

Neuroscience – Mood Disorders – Alzheimer’s Disease

Infectious Diseases and Vaccines

– Hepatitis – Respiratory Infections

Immunology – Rheumatoid Arthritis – Inflammatory Bowl Disease – Psoriasis – Pulmonary

Oncology – Prostate Cancer – Lung Cancer – Hematologic Malignancies

9 9

Innovation Centres in Review

Catalyzing innovation at Johnson & Johnson is about creating strong networks of people who can combine resources, ideas and technologies in a new way.”

“

Paul Stoffels, MD Chief Scientific Officer